Immune Repertoire Sequencing Market Size & Share, Product Type (Instruments, Assay Kits); Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development, Efficacy, Transplant Rejection, Tolerance, Infectious Diseases); End-user (Pharmaceutical Companies, Research Institutes, Diagnostic Labs) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3997
  • Published Date: Aug 07, 2023
  • Report Format: PDF, PPT

Companies Dominating the Immune Repertoire Sequencing Market

    • Agilent Technologies, Inc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Illumina, Inc.
    • Pacific Biosciences of California, Inc
    • QIAGEN N.V.
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche AG
    • Takara Bio, Inc
    • Oxford Nanopore Technologies, Ltd
    • BGI Group
    • Atreca Inc

Browse Key Market Insights with Data Illustration:


In The News

  • BGI and Gencove announced the extension of the agreement for offering low-pass whole genome sequencing and analysis service to improve global health and sustainability.
  • Thermo Fisher introduced a new suite of immune repertoire assays that will help identify potentially malignant clones of T-cells and B-cells.

Author Credits:  Smruti Ranjan, Rajrani Baghel

  • Report ID: 3997
  • Published Date: Aug 07, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving market growth are the increasing number of launches of novel products, and rising government funding to improve the healthcare infrastructure.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Agilent Technologies, Inc, Illumina, Inc., Pacific Biosciences of California, Inc, QIAGEN N.V., Thermo Fisher Scientific, Inc., and others.

The pharmaceutical companies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying